ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesM84.50

M84.50

Billable

Pathological fracture in neoplastic disease, unspecified site

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/17/2025

Code Description

ICD-10 M84.50 is a billable code used to indicate a diagnosis of pathological fracture in neoplastic disease, unspecified site.

Key Diagnostic Point:

Pathological fractures occur when bones weaken due to underlying conditions, such as neoplastic diseases, which include various types of cancers. These fractures are not the result of trauma but rather the consequence of the disease process itself, where the integrity of the bone is compromised. In neoplastic diseases, tumors can invade bone tissue, leading to decreased bone density and structural integrity. This results in an increased risk of fractures, even with minimal or no trauma. The unspecified site indicates that the fracture location is not specified, which can complicate treatment and management. Patients with conditions such as osteoporosis, which is characterized by reduced bone mass and density, are particularly vulnerable to these types of fractures. The management of pathological fractures in neoplastic disease often involves a multidisciplinary approach, including oncologists, orthopedic surgeons, and rehabilitation specialists, to address both the fracture and the underlying malignancy. Understanding the relationship between bone metabolism, density disorders, and neoplastic diseases is crucial for effective treatment and prevention strategies.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in documentation regarding the site of fracture
  • Need for clear differentiation between traumatic and pathological fractures
  • Potential for multiple underlying neoplastic conditions
  • Variability in treatment approaches based on cancer type and location

Audit Risk Factors

  • Inadequate documentation of the neoplastic disease
  • Failure to specify the fracture site when applicable
  • Lack of clarity on whether the fracture is pathological or traumatic
  • Inconsistent coding practices among different providers

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed documentation of the type and stage of neoplastic disease, treatment history, and any imaging studies.

Common Clinical Scenarios

Patients presenting with fractures during or after cancer treatment, particularly those with metastatic disease.

Billing Considerations

Ensure that the relationship between the neoplastic disease and the fracture is clearly established in the documentation.

Orthopedics

Documentation Requirements

Comprehensive assessment of the fracture, including imaging results and treatment plans.

Common Clinical Scenarios

Management of fractures in patients with known malignancies, particularly in weight-bearing bones.

Billing Considerations

Documentation should include the mechanism of injury and any relevant history of bone density disorders.

Coding Guidelines

Inclusion Criteria

Use M84.50 When
  • According to ICD
  • 10 coding guidelines, M84
  • 50 should be used when a pathological fracture is confirmed in a patient with a neoplastic disease, and the specific site of the fracture is not documented
  • Coders should ensure that the underlying neoplastic condition is well
  • documented to support the use of this code

Exclusion Criteria

Do NOT use M84.50 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

20610CPT Code

Arthrocentesis, aspiration and/or injection into a major joint or bursa

Clinical Scenario

Used in conjunction with M84.50 when managing joint effusions related to fractures.

Documentation Requirements

Document the reason for the procedure and the findings during the aspiration.

Specialty Considerations

Orthopedic specialists should ensure that the procedure is justified based on the patient's fracture and underlying condition.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of pathological fractures, improving the ability to track and manage these cases. M84.50 provides a clear designation for fractures related to neoplastic diseases, which aids in research and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of pathological fractures, improving the ability to track and manage these cases. M84.50 provides a clear designation for fractures related to neoplastic diseases, which aids in research and treatment planning.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of pathological fractures, improving the ability to track and manage these cases. M84.50 provides a clear designation for fractures related to neoplastic diseases, which aids in research and treatment planning.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between a pathological fracture and a traumatic fracture?

A pathological fracture occurs due to weakened bone structure from underlying conditions, such as cancer, while a traumatic fracture results from an external force or injury.

When should I use M84.50 instead of a more specific code?

Use M84.50 when the fracture site is not specified and the patient has a documented neoplastic disease. If the site is known, use the corresponding specific code.